ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Fibrinogen Market Research Report 2026
Published Date: 2026-02-10
|
Report Code: QYRE-Auto-8161
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Human Fibrinogen Market Insights and Forecast to 2028
BUY CHAPTERS

Global Human Fibrinogen Market Research Report 2026

Code: QYRE-Auto-8161
Report
2026-02-10
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Behring
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
Shanghai RAAS Blood Products
Octapharma AG
LFB Group
China Resources Boya Bio-Pharmaceutical
China Meheco Group

Human Fibrinogen Market Size

The global Human Fibrinogen market was valued at US$ 1407 million in 2025 and is anticipated to reach US$ 2804 million by 2032, at a CAGR of 10.5% from 2026 to 2032.

Human Fibrinogen Market

Human Fibrinogen Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Human Fibrinogen competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Human Fibrinogen is a high-purity plasma protein preparation derived from human plasma or produced through recombinant technology, with fibrinogen as its main component. It plays a crucial role in blood clotting, as fibrinogen is converted into fibrin by thrombin to form a blood clot and stop bleeding. Fibrinogen concentrate is primarily used to treat congenital or acquired fibrinogen deficiencies, manage bleeding during surgery or trauma, and address other conditions requiring rapid fibrinogen supplementation.
The market for fibrinogen concentrate is primarily driven by the increasing prevalence of bleeding disorders and surgical procedures that require rapid hemostasis, as well as growing awareness and adoption of targeted blood management therapies. Advances in plasma fractionation and recombinant technologies, along with rising demand for safer, pathogen-reduced, and high-purity blood products, are also fueling market growth. Additionally, an aging population, higher incidence of trauma and cardiovascular surgeries, and expansion of healthcare infrastructure in emerging regions contribute to the increasing demand for fibrinogen concentrate.
Global Human Fibrinogen key players include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, GREEN CROSS, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest consumption market, with a share about 60%, followed by Americas and Europe, total have a share over 30 percent. In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%. And in terms of application, the largest application is Surgical Procedures.
This report delivers a comprehensive overview of the global Human Fibrinogen market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human Fibrinogen. The Human Fibrinogen market size, estimates, and forecasts are provided in terms of sales volume (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Human Fibrinogen market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human Fibrinogen manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Human Fibrinogen Market Report

Report Metric Details
Report Name Human Fibrinogen Market
Accounted market size in 2025 US$ 1407 million
Forecasted market size in 2032 US$ 2804 million
CAGR 10.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Human Fibrinogen Concentrate
  • Animal Fibrinogen Concentrate
by Application
  • Congenital Fibrinogen Deficiency
  • Surgical Procedures
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL Behring, LFB Group, Shanghai RAAS Blood Products, China Resources Boya Bio-pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, China Meheco Group, Octapharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Human Fibrinogen manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Human Fibrinogen sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Human Fibrinogen Market growing?

Ans: The Human Fibrinogen Market witnessing a CAGR of 10.5% during the forecast period 2026-2032.

What is the Human Fibrinogen Market size in 2032?

Ans: The Human Fibrinogen Market size in 2032 will be US$ 2804 million.

What is the market share of major companies in Human Fibrinogen Market?

Ans: Global top five manufacturers hold a share about 90%.

What is the Human Fibrinogen Market share by type?

Ans: In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%.

Who are the main players in the Human Fibrinogen Market report?

Ans: The main players in the Human Fibrinogen Market are CSL Behring, LFB Group, Shanghai RAAS Blood Products, China Resources Boya Bio-pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, China Meheco Group, Octapharma

What are the Application segmentation covered in the Human Fibrinogen Market report?

Ans: The Applications covered in the Human Fibrinogen Market report are Congenital Fibrinogen Deficiency, Surgical Procedures, Others

What are the Type segmentation covered in the Human Fibrinogen Market report?

Ans: The Types covered in the Human Fibrinogen Market report are Human Fibrinogen Concentrate, Animal Fibrinogen Concentrate

1 Human Fibrinogen Market Overview
1.1 Product Definition
1.2 Human Fibrinogen by Type
1.2.1 Global Human Fibrinogen Market Value by Type: 2025 vs 2032
1.2.2 Human Fibrinogen Concentrate
1.2.3 Animal Fibrinogen Concentrate
1.3 Human Fibrinogen by Application
1.3.1 Global Human Fibrinogen Market Value by Application: 2025 vs 2032
1.3.2 Congenital Fibrinogen Deficiency
1.3.3 Surgical Procedures
1.3.4 Others
1.4 Global Human Fibrinogen Market Size Estimates and Forecasts
1.4.1 Global Human Fibrinogen Revenue 2021–2032
1.4.2 Global Human Fibrinogen Sales 2021–2032
1.4.3 Global Human Fibrinogen Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Human Fibrinogen Market Competition by Manufacturers
2.1 Global Human Fibrinogen Sales Market Share by Manufacturers (2021–2026)
2.2 Global Human Fibrinogen Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Human Fibrinogen Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Human Fibrinogen, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Human Fibrinogen, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Human Fibrinogen, Product Types and Applications
2.7 Global Key Manufacturers of Human Fibrinogen, Date of Entry into the Industry
2.8 Global Human Fibrinogen Market Competitive Situation and Trends
2.8.1 Global Human Fibrinogen Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Human Fibrinogen Players Market Share by Revenue
2.8.3 Global Human Fibrinogen Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Fibrinogen Market Scenario by Region
3.1 Global Human Fibrinogen Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Human Fibrinogen Sales by Region: 2021–2032
3.2.1 Global Human Fibrinogen Sales by Region: 2021–2026
3.2.2 Global Human Fibrinogen Sales by Region: 2027–2032
3.3 Global Human Fibrinogen Revenue by Region: 2021–2032
3.3.1 Global Human Fibrinogen Revenue by Region: 2021–2026
3.3.2 Global Human Fibrinogen Revenue by Region: 2027–2032
3.4 North America Human Fibrinogen Market Facts & Figures by Country
3.4.1 North America Human Fibrinogen Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Human Fibrinogen Sales by Country (2021–2032)
3.4.3 North America Human Fibrinogen Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Fibrinogen Market Facts & Figures by Country
3.5.1 Europe Human Fibrinogen Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Human Fibrinogen Sales by Country (2021–2032)
3.5.3 Europe Human Fibrinogen Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Fibrinogen Market Facts & Figures by Region
3.6.1 Asia Pacific Human Fibrinogen Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Human Fibrinogen Sales by Region (2021–2032)
3.6.3 Asia Pacific Human Fibrinogen Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Fibrinogen Market Facts & Figures by Country
3.7.1 Latin America Human Fibrinogen Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Human Fibrinogen Sales by Country (2021–2032)
3.7.3 Latin America Human Fibrinogen Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Fibrinogen Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Fibrinogen Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Human Fibrinogen Sales by Country (2021–2032)
3.8.3 Middle East and Africa Human Fibrinogen Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Fibrinogen Sales by Type (2021–2032)
4.1.1 Global Human Fibrinogen Sales by Type (2021–2026)
4.1.2 Global Human Fibrinogen Sales by Type (2027–2032)
4.1.3 Global Human Fibrinogen Sales Market Share by Type (2021–2032)
4.2 Global Human Fibrinogen Revenue by Type (2021–2032)
4.2.1 Global Human Fibrinogen Revenue by Type (2021–2026)
4.2.2 Global Human Fibrinogen Revenue by Type (2027–2032)
4.2.3 Global Human Fibrinogen Revenue Market Share by Type (2021–2032)
4.3 Global Human Fibrinogen Price by Type (2021–2032)
5 Segment by Application
5.1 Global Human Fibrinogen Sales by Application (2021–2032)
5.1.1 Global Human Fibrinogen Sales by Application (2021–2026)
5.1.2 Global Human Fibrinogen Sales by Application (2027–2032)
5.1.3 Global Human Fibrinogen Sales Market Share by Application (2021–2032)
5.2 Global Human Fibrinogen Revenue by Application (2021–2032)
5.2.1 Global Human Fibrinogen Revenue by Application (2021–2026)
5.2.2 Global Human Fibrinogen Revenue by Application (2027–2032)
5.2.3 Global Human Fibrinogen Revenue Market Share by Application (2021–2032)
5.3 Global Human Fibrinogen Price by Application (2021–2032)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Human Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 CSL Behring Human Fibrinogen Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 LFB Group
6.2.1 LFB Group Company Information
6.2.2 LFB Group Description and Business Overview
6.2.3 LFB Group Human Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 LFB Group Human Fibrinogen Product Portfolio
6.2.5 LFB Group Recent Developments/Updates
6.3 Shanghai RAAS Blood Products
6.3.1 Shanghai RAAS Blood Products Company Information
6.3.2 Shanghai RAAS Blood Products Description and Business Overview
6.3.3 Shanghai RAAS Blood Products Human Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Shanghai RAAS Blood Products Human Fibrinogen Product Portfolio
6.3.5 Shanghai RAAS Blood Products Recent Developments/Updates
6.4 China Resources Boya Bio-pharmaceutical
6.4.1 China Resources Boya Bio-pharmaceutical Company Information
6.4.2 China Resources Boya Bio-pharmaceutical Description and Business Overview
6.4.3 China Resources Boya Bio-pharmaceutical Human Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 China Resources Boya Bio-pharmaceutical Human Fibrinogen Product Portfolio
6.4.5 China Resources Boya Bio-pharmaceutical Recent Developments/Updates
6.5 Hualan Biological Engineering
6.5.1 Hualan Biological Engineering Company Information
6.5.2 Hualan Biological Engineering Description and Business Overview
6.5.3 Hualan Biological Engineering Human Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Hualan Biological Engineering Human Fibrinogen Product Portfolio
6.5.5 Hualan Biological Engineering Recent Developments/Updates
6.6 Harbin Pacific Biopharmaceutical
6.6.1 Harbin Pacific Biopharmaceutical Company Information
6.6.2 Harbin Pacific Biopharmaceutical Description and Business Overview
6.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Product Portfolio
6.6.5 Harbin Pacific Biopharmaceutical Recent Developments/Updates
6.7 China Meheco Group
6.7.1 China Meheco Group Company Information
6.7.2 China Meheco Group Description and Business Overview
6.7.3 China Meheco Group Human Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 China Meheco Group Human Fibrinogen Product Portfolio
6.7.5 China Meheco Group Recent Developments/Updates
6.8 Octapharma
6.8.1 Octapharma Company Information
6.8.2 Octapharma Description and Business Overview
6.8.3 Octapharma Human Fibrinogen Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Octapharma Human Fibrinogen Product Portfolio
6.8.5 Octapharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Fibrinogen Industry Chain Analysis
7.2 Human Fibrinogen Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Fibrinogen Production Mode & Process Analysis
7.4 Human Fibrinogen Sales and Marketing
7.4.1 Human Fibrinogen Sales Channels
7.4.2 Human Fibrinogen Distributors
7.5 Human Fibrinogen Customer Analysis
8 Human Fibrinogen Market Dynamics
8.1 Human Fibrinogen Industry Trends
8.2 Human Fibrinogen Market Drivers
8.3 Human Fibrinogen Market Challenges
8.4 Human Fibrinogen Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CSL Behring
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
Shanghai RAAS Blood Products
Octapharma AG
LFB Group
China Resources Boya Bio-Pharmaceutical
China Meheco Group
List of Tables
 Table 1. Global Human Fibrinogen Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Human Fibrinogen Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Human Fibrinogen Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Human Fibrinogen Sales (Kg) of Key Manufacturers (2021–2026)
 Table 5. Global Human Fibrinogen Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Human Fibrinogen Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Human Fibrinogen Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Human Fibrinogen Average Price (USD/Kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Human Fibrinogen, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Human Fibrinogen, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Human Fibrinogen, Product Types and Applications
 Table 12. Global Key Manufacturers of Human Fibrinogen, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Fibrinogen Companies by Tier (Tier 1, Tier 2, Tier 3), based on Human Fibrinogen Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Fibrinogen Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Human Fibrinogen Sales by Region (Kg), 2021–2026
 Table 18. Global Human Fibrinogen Sales Market Share by Region (2021–2026)
 Table 19. Global Human Fibrinogen Sales by Region (Kg), 2027–2032
 Table 20. Global Human Fibrinogen Sales Market Share by Region (2027–2032)
 Table 21. Global Human Fibrinogen Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Human Fibrinogen Revenue Market Share by Region (2021–2026)
 Table 23. Global Human Fibrinogen Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Human Fibrinogen Revenue Market Share by Region (2027–2032)
 Table 25. North America Human Fibrinogen Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Human Fibrinogen Sales by Country (Kg), 2021–2026
 Table 27. North America Human Fibrinogen Sales by Country (Kg), 2027–2032
 Table 28. North America Human Fibrinogen Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Human Fibrinogen Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Human Fibrinogen Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Human Fibrinogen Sales by Country (Kg), 2021–2026
 Table 32. Europe Human Fibrinogen Sales by Country (Kg), 2027–2032
 Table 33. Europe Human Fibrinogen Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Human Fibrinogen Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Human Fibrinogen Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Human Fibrinogen Sales by Region (Kg), 2021–2026
 Table 37. Asia Pacific Human Fibrinogen Sales by Region (Kg), 2027–2032
 Table 38. Asia Pacific Human Fibrinogen Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Human Fibrinogen Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Human Fibrinogen Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Human Fibrinogen Sales by Country (Kg), 2021–2026
 Table 42. Latin America Human Fibrinogen Sales by Country (Kg), 2027–2032
 Table 43. Latin America Human Fibrinogen Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Human Fibrinogen Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Human Fibrinogen Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Human Fibrinogen Sales by Country (Kg), 2021–2026
 Table 47. Middle East and Africa Human Fibrinogen Sales by Country (Kg), 2027–2032
 Table 48. Middle East and Africa Human Fibrinogen Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Human Fibrinogen Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Human Fibrinogen Sales (Kg) by Type (2021–2026)
 Table 51. Global Human Fibrinogen Sales (Kg) by Type (2027–2032)
 Table 52. Global Human Fibrinogen Sales Market Share by Type (2021–2026)
 Table 53. Global Human Fibrinogen Sales Market Share by Type (2027–2032)
 Table 54. Global Human Fibrinogen Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Human Fibrinogen Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Human Fibrinogen Revenue Market Share by Type (2021–2026)
 Table 57. Global Human Fibrinogen Revenue Market Share by Type (2027–2032)
 Table 58. Global Human Fibrinogen Price (USD/Kg) by Type (2021–2026)
 Table 59. Global Human Fibrinogen Price (USD/Kg) by Type (2027–2032)
 Table 60. Global Human Fibrinogen Sales (Kg) by Application (2021–2026)
 Table 61. Global Human Fibrinogen Sales (Kg) by Application (2027–2032)
 Table 62. Global Human Fibrinogen Sales Market Share by Application (2021–2026)
 Table 63. Global Human Fibrinogen Sales Market Share by Application (2027–2032)
 Table 64. Global Human Fibrinogen Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Human Fibrinogen Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Human Fibrinogen Revenue Market Share by Application (2021–2026)
 Table 67. Global Human Fibrinogen Revenue Market Share by Application (2027–2032)
 Table 68. Global Human Fibrinogen Price (USD/Kg) by Application (2021–2026)
 Table 69. Global Human Fibrinogen Price (USD/Kg) by Application (2027–2032)
 Table 70. CSL Behring Company Information
 Table 71. CSL Behring Description and Business Overview
 Table 72. CSL Behring Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 73. CSL Behring Human Fibrinogen Product
 Table 74. CSL Behring Recent Developments/Updates
 Table 75. LFB Group Company Information
 Table 76. LFB Group Description and Business Overview
 Table 77. LFB Group Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 78. LFB Group Human Fibrinogen Product
 Table 79. LFB Group Recent Developments/Updates
 Table 80. Shanghai RAAS Blood Products Company Information
 Table 81. Shanghai RAAS Blood Products Description and Business Overview
 Table 82. Shanghai RAAS Blood Products Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 83. Shanghai RAAS Blood Products Human Fibrinogen Product
 Table 84. Shanghai RAAS Blood Products Recent Developments/Updates
 Table 85. China Resources Boya Bio-pharmaceutical Company Information
 Table 86. China Resources Boya Bio-pharmaceutical Description and Business Overview
 Table 87. China Resources Boya Bio-pharmaceutical Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 88. China Resources Boya Bio-pharmaceutical Human Fibrinogen Product
 Table 89. China Resources Boya Bio-pharmaceutical Recent Developments/Updates
 Table 90. Hualan Biological Engineering Company Information
 Table 91. Hualan Biological Engineering Description and Business Overview
 Table 92. Hualan Biological Engineering Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 93. Hualan Biological Engineering Human Fibrinogen Product
 Table 94. Hualan Biological Engineering Recent Developments/Updates
 Table 95. Harbin Pacific Biopharmaceutical Company Information
 Table 96. Harbin Pacific Biopharmaceutical Description and Business Overview
 Table 97. Harbin Pacific Biopharmaceutical Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 98. Harbin Pacific Biopharmaceutical Human Fibrinogen Product
 Table 99. Harbin Pacific Biopharmaceutical Recent Developments/Updates
 Table 100. China Meheco Group Company Information
 Table 101. China Meheco Group Description and Business Overview
 Table 102. China Meheco Group Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 103. China Meheco Group Human Fibrinogen Product
 Table 104. China Meheco Group Recent Developments/Updates
 Table 105. Octapharma Company Information
 Table 106. Octapharma Description and Business Overview
 Table 107. Octapharma Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 108. Octapharma Human Fibrinogen Product
 Table 109. Octapharma Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Human Fibrinogen Distributors List
 Table 113. Human Fibrinogen Customers List
 Table 114. Human Fibrinogen Market Trends
 Table 115. Human Fibrinogen Market Drivers
 Table 116. Human Fibrinogen Market Challenges
 Table 117. Human Fibrinogen Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Fibrinogen
 Figure 2. Global Human Fibrinogen Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Human Fibrinogen Market Share by Type: 2025 & 2032
 Figure 4. Human Fibrinogen Concentrate Product Picture
 Figure 5. Animal Fibrinogen Concentrate Product Picture
 Figure 6. Global Human Fibrinogen Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Human Fibrinogen Market Share by Application: 2025 & 2032
 Figure 8. Congenital Fibrinogen Deficiency
 Figure 9. Surgical Procedures
 Figure 10. Others
 Figure 11. Global Human Fibrinogen Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Human Fibrinogen Market Size (US$ Million), 2021–2032
 Figure 13. Global Human Fibrinogen Sales (Kg), 2021–2032
 Figure 14. Global Human Fibrinogen Average Price (USD/Kg), 2021–2032
 Figure 15. Human Fibrinogen Report Years Considered
 Figure 16. Human Fibrinogen Sales Share by Manufacturers in 2025
 Figure 17. Global Human Fibrinogen Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Human Fibrinogen Players: Market Share by Revenue in Human Fibrinogen in 2025
 Figure 19. Human Fibrinogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Human Fibrinogen Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Human Fibrinogen Sales Market Share by Country (2021–2032)
 Figure 22. North America Human Fibrinogen Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Human Fibrinogen Sales Market Share by Country (2021–2032)
 Figure 26. Europe Human Fibrinogen Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Human Fibrinogen Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Human Fibrinogen Revenue Market Share by Region (2021–2032)
 Figure 34. China Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Taiwan Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Philippines Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Human Fibrinogen Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Human Fibrinogen Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Human Fibrinogen Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Human Fibrinogen Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. U.A.E Human Fibrinogen Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Human Fibrinogen by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Human Fibrinogen by Type (2021–2032)
 Figure 56. Global Human Fibrinogen Price (USD/Kg) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Human Fibrinogen by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Human Fibrinogen by Application (2021–2032)
 Figure 59. Global Human Fibrinogen Price (USD/Kg) by Application (2021–2032)
 Figure 60. Human Fibrinogen Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Fibrinogen Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Animal Fibrinogen Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fibrinogen Concentrate Market Research Report 2025
Human Fibrinogen Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fibrinogen Reagent Kits Market Insights Forecast to 2030
Human Fibrin Glue Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fibrinogen Testing Reagents Market Insights Forecast to 2030
Global Human Blood Products Market Research Report 2025
Human Coagulation Factor Ⅷ Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fibrin Specific Drugs Market Research Report 2024
Global Human Coagulation Factor VII Market Insights Forecast to 2030
Global Fibrin Sealant Product Market Research Report 2024
Clotting Factor Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plasma Protein Products Market Research Report 2024
Blood Coagulation Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fibrinogen Deficiency Drug Market Research Report 2025
Blood Coagulation Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fibrin Glue Hemostat Market Research Report 2024
Global Clotting Factors Ⅷ Market Insights Forecast to 2030
Global Clotting Factor Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions